As previously reported, the disturbance in β-oxidation of fatty acids owing to down-regulation of hepatic CPT-1α is a key mechanism in pathogenesis of fatty liver in metabolic syndrome (33, 34). This evidence concerns the gene CPT1A and Hepatic steatosis.